RXO (NYSE:RXO) Coverage Initiated at Morgan Stanley

Equities research analysts at Morgan Stanley started coverage on shares of RXO (NYSE:RXOGet Rating) in a note issued to investors on Friday, The Fly reports. The brokerage set an “equal weight” rating on the stock.

Several other equities analysts also recently issued reports on the stock. The Goldman Sachs Group assumed coverage on shares of RXO in a research note on Tuesday, November 22nd. They set a “neutral” rating and a $20.00 price objective on the stock. Bank of America initiated coverage on RXO in a research note on Wednesday, November 30th. They set a “buy” rating and a $22.00 price target on the stock. Jefferies Financial Group began coverage on RXO in a research report on Tuesday. They issued a “buy” rating and a $25.00 price objective for the company. Stephens initiated coverage on RXO in a research note on Wednesday, November 2nd. They issued an “equal weight” rating for the company. Finally, Raymond James began coverage on RXO in a research note on Monday. They issued a “market perform” rating on the stock. Five analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $22.50.

RXO Trading Down 1.3 %

NYSE:RXO opened at $17.89 on Friday. RXO has a 12-month low of $14.75 and a 12-month high of $25.50. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.01.

About RXO

(Get Rating)

RXO provides truckload freight transportation brokerage in the United States. The company, through a proprietary digital freight marketplace, offers access to truckload capacity and complementary brokered services of managed transportation, last mile, and freight forwarding. The company is based in Charlotte, North Carolina.

See Also

The Fly logo

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.